November 4, 2025
IMPORTANT: Vaccine Update(s) The CDC recently issued important vaccination guidance updates.NOTE: Our 2025-26 Vaccination Program Administration Guidelines have been revised to reflect these updates*. ➀ COVID-19 Vaccine COVID-19 vaccination is recommended for everyone 6 months and older following shared medical decision-making between the individual and their healthcare provider(s). Vaccination is especially important for people at…
May 6, 2025
About Pneumococcal Infection and Disease Pneumococcal disease is a term used for a wide range of infections caused by bacteria called Streptococcuspneumoniae (pneumococcus). Ear and sinus infections are examples of mild infections these bacteria can cause. The following types of pneumococcal disease can be very serious, even deadly: Invasive pneumococcal disease (IPD) means the bacteria…
August 9, 2022
CDC’s Updated Pneumococcal Recommendations for Adults Compared to Prevnar 13, Vaxneuvance protects against 2 additional serotypes and Prevnar 20 protects against 7 additional serotypes involved in cases of invasive pneumococcal disease (IPD) and pneumonia. IPD and pneumonia are responsible for up to 40% of all pneumococcal disease and related deaths in the US. For those…
February 24, 2022
CDC’s Updated Pneumococcal Recommendations for Adults (Feb 2022) Two types of pneumococcal vaccines are available in the US: Pneumococcal polysaccharide vaccines: PPSV23 (Pneumovax) Pneumococcal conjugate vaccines: PCV13 (Prevnar 13) and 2 new conjugate vaccines: PCV15 (Prevnar 15) and PCV20 (Prevnar 20) Compared to Prevnar 13, Prevnar 15 protects against 2 additional serotypes and Prevnar 20…